Relmada Therapeutics, Inc. (RLMD)

Relmada Therapeutics Statistics

Total Valuation

RLMD has a market cap or net worth of $291.13 million. The enterprise value is $277.25 million.

Market Cap	291.13M
Enterprise Value	277.25M

Important Dates

The last earnings date was Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

RLMD has 73.33 million shares outstanding. The number of shares has increased by 5.32% in one year.

Current Share Class	73.33M
Shares Outstanding	73.33M
Shares Change (YoY)	+5.32%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.64%
Owned by Institutions (%)	15.11%
Float	65.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	13.92
P/TBV Ratio	30.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.86

Current Ratio	2.86
Quick Ratio	2.68
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -196.79% and return on invested capital (ROIC) is -126.65%.

Return on Equity (ROE)	-196.79%
Return on Assets (ROA)	-102.41%
Return on Invested Capital (ROIC)	-126.65%
Return on Capital Employed (ROCE)	-597.14%
Revenue Per Employee	n/a
Profits Per Employee	-$3.30M
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +31.89% in the last 52 weeks. The beta is 0.83, so RLMD's price volatility has been lower than the market average.

Beta (5Y)	0.83
52-Week Price Change	+31.89%
50-Day Moving Average	2.23
200-Day Moving Average	0.95
Relative Strength Index (RSI)	78.55
Average Volume (20 Days)	1,824,800

Short Selling Information

The latest short interest is 514,106, so 0.70% of the outstanding shares have been sold short.

Short Interest	514,106
Short Previous Month	562,426
Short % of Shares Out	0.70%
Short % of Float	0.79%
Short Ratio (days to cover)	1.72

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-57.84M
Pretax Income	-56.17M
Net Income	-56.17M
EBITDA	n/a
EBIT	-57.84M
Earnings Per Share (EPS)	-$1.77

Balance Sheet

The company has $13.89 million in cash and n/a in debt, giving a net cash position of $13.89 million or $0.19 per share.

Cash & Cash Equivalents	13.89M
Total Debt	n/a
Net Cash	13.89M
Net Cash Per Share	$0.19
Equity (Book Value)	9.47M
Book Value Per Share	0.29
Working Capital	9.66M

Cash Flow

Operating Cash Flow	-39.99M
Capital Expenditures	n/a
Free Cash Flow	-39.99M
FCF Per Share	-$0.55

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RLMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.32%
Shareholder Yield	-5.32%
Earnings Yield	-19.30%
FCF Yield	-13.74%

Analyst Forecast

The average price target for RLMD is $1.00, which is -74.81% lower than the current price. The consensus rating is "Hold".

Price Target	$1.00
Price Target Difference	-74.81%
Analyst Consensus	Hold
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-23.08%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 30, 2019. It was a reverse split with a ratio of 1:4.

Last Split Date	Sep 30, 2019
Split Type	Reverse
Split Ratio	1:4

Scores

Altman Z-Score	n/a
Piotroski F-Score	1